Erratum: Adherence and persistence with drug therapy among fibromyalgia patients: Data from a large health maintenance organization (Journal of Rheumatology (2017) DOI: 10.3899/jrheum.170098);Adherence and persistence with drug therapy among fibromyalgia patients: Data from a large health maintenance organization

Journal of Rheumatology

Volumn 44, Issue 10, 2017, Pages 1499-1506

  Shor, Dana Ben Ami ^a   Weitzman, Dahlia ^a   Dahan, Shani ^a   Gendelman, Omer ^a   Bar On, Yael ^a   Amital, Daniela ^a   Shalev, Varda ^a   Chodick, Gabriel ^a   Amital, Howard ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adherence; Anticonvulsants; Antidepressants; Compliance; Fibromyalgia; Persistence

Indexed keywords

NORADRENALIN UPTAKE INHIBITOR; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT;

ADULT; AGE; ANXIETY DISORDER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG WITHDRAWAL; FEMALE; FIBROMYALGIA; FOLLOW UP; GENERAL PRACTITIONER; HOSPITALIZATION; HUMAN; IMMIGRANT; ISRAEL; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIAL STATUS; HEALTH MAINTENANCE ORGANIZATION; MEDICATION COMPLIANCE; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; FEMALE; FIBROMYALGIA; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; ISRAEL; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85030320122     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.170098.C1     Document Type: Erratum

References (28)

1. Bazzichi L, Giacomelli C, Consensi A, Atzeni F, Batticciotto A, Di Franco M, et al. One year in review 2016: fibromyalgia. Clin Exp Rheumatol 2016;34 Suppl 96:S145-9.
2. Borchers AT, Gershwin ME. Fibromyalgia: a critical and comprehensive review. Clin Rev Allergy Immunol 2015;49:100-51.
3. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013;17:356.
4. Ablin JN, Buskila D, Van Houdenhove B, Luyten P, Atzeni F, Sarzi-Puttini P. Is fibromyalgia a discrete entity? Autoimmun Rev 2012;11:585-8.
5. Arnold LM, Choy E, Clauw DJ, Goldenberg DL, Harris RE, Helfenstein M Jr, et al. Fibromyalgia and chronic pain syndromes: a white paper detailing current challenges in the field. Clin J Pain 2016;32:737-46.
6. Fitzcharles MA, Shir Y, Ablin JN, Buskila D, Amital H, Henningsen P, et al. Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines. Evid Based Complement Alternat Med 2013;2013:528952.
7. Okifuji A, Hare BD. Management of fibromyalgia syndrome: review of evidence. Pain Ther 2013;2:87-104.
8. Butow P, Sharpe L. The impact of communication on adherence in pain management. Pain 2013;154 Suppl 1:S101-7.
9. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.
10. Zandman-Goddard G, Amital H, Shamrayevsky N, Raz R, Shalev V, Chodick G. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatology 2013; 52:1126-31.
11. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7.
12. Zhao Y, Chen SY, Wu N, Fraser KA, Boulanger L. Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine. Pain Pract 2011;11:381-91.
13. Kim SC, Landon JE, Solomon DH. Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalin. Arthritis Care Res 2013;65:1813-9.
14. Amital H, Arnson Y, Chodick G, Shalev V. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate. Rheumatology 2009;48:1107-10.
15. Chodick G, Amital H, Shalem Y, Kokia E, Heymann AD, Porath A, et al. Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study. PLoS Med 2010;7:e1000336.
16. Chodick G, Weitzman D, Shalev V, Weil C, Amital H. Adherence to statins and the risk of psoriasis: a population-based cohort study. Br J Dermatol 2015;173:480-7.
17. Dar L, Shalev V, Weitzman D, Chodick G, Arnson Y, Amital H. No male predominance in offspring of women with rheumatoid arthritis or systemic lupus erythematosus. Immunol Res 2014;60:361-5.
18. Burck L. Characterization and classification of geographical units by the socio-economic level of the population. Tsibel N, editor. Israel: Central Bureau of Statistics; 2013.
19. Seidel MF, Müller W. Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists. Expert Opin Pharmacother 2011;2:1381-91.
20. Liu Y, Qian C, Yang M. Treatment patterns associated with ACR-recommended medications in the management of fibromyalgia in the United States. J Manag Care Spec Pharm 2016;22:263-71.
21. Cui Z, Zhao Y, Novick D, Faries D. Predictors of duloxetine adherence and persistence in patients with fibromyalgia. J Pain Res 2012;5:193-201.
22. Bauer LK, Caro MA, Beach SR, Mastromauro CA, Lenihan E, Januzzi JL, et al. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol 2012;109:1266-71.
23. Robinson RL, Kroenke K, Williams DA, Mease P, Chen Y, Faries D, et al. Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the reflections study. Pain Med 2013;14:1400-15.
24. Wolfe F, Walitt BT, Katz RS, Lee YC, Michaud KD, Häuser W. Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia. Eur J Pain 2013;17:581-6.
25. Cooper TE, Derry S, Wiffen PJ, Moore RA. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev 2017;1:CD012188.
26. Derry S, Cording M, Wiffen PJ, Law S, Phillips T, Moore RA. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev 2016;9:CD011790.
27. Häuser W, Urrútia G, Tort S, Uçeyler N, Walitt B. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev 2013;1:CD010292.
28. Moore RA, Cai N, Skljarevski V, Tölle TR. Duloxetine use in chronic painful conditions - individual patient data responder analysis. Eur J Pain 2014;18:67-75.